Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00203853 · ClinicalTrials.gov registry record · NA

Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults

A NA study, sponsored by University of Chicago.

Terminated
Registry status
NA
Development phase
200
Enrollment target

NCT00203853: Clinical Trial NA study, sponsored by University of Chicago.

NCT00203853 is a NA study that was terminated before completion, run by University of Chicago. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00203853, a NA study, was terminated before completion, sponsored by University of Chicago.

TERMINATED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

It is known successful HIV therapy depends on the patients' ability to take their medicine regularly. This study is designed to find out if an intervention designed to help patients remember to take their medication is effective. The intervention consists of a wristwatch that has an alarm to remind patients when to take their medication, a pillbox and three monthly phone calls by a physician. All these experimental measures are meant to improve the ability of patients to take their medicines.

Interventions

  • DEVICE pillbox, wristwatch

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2005-01
Est. Completion 2007-03
Phase NA
University of Chicago

796 total trials

Why NCT00203853 stopped before completion

NCT00203853 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).

The record links to 0 conditions, and to 1 intervention - of which pillbox, wristwatch is the first listed.

NCT00203853 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00203853 about?

NCT00203853 is a clinical study titled "Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults". It is known successful HIV therapy depends on the patients' ability to take their medicine regularly. This study is designed to find out if an intervention designed to help patients remember to take their medication is effective. The intervention consists of a wristwatch that has an alarm to remind ...

What is the current status of trial NCT00203853?

This trial is currently terminated. It is a NA study. The enrollment target is 200 participants. The study started on 2005-01. Estimated completion is 2007-03.

What interventions are being tested in trial NCT00203853?

The interventions under investigation include: pillbox, wristwatch (DEVICE).

Who is sponsoring clinical trial NCT00203853?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00203853's enrollment target sits among peer trials

200 506th of 2000 higher than 1,434 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00107289 · 200 participants · Phase 2

    Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

  • NCT00109174 · 200 participants · NA

    MRS Measurement of Glutamate and GABA Metabolism in Brain

  • NCT00177268 · 200 participants

    Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

  • NCT00493688 · 200 participants

    A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00203853, the US trial registry maintained by the National Library of Medicine. NCT00203853 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.